Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD [5]

European Respiratory Journal

Volumn 30, Issue 4, 2007, Pages 811-812

  Chappell, S ^a   Daly, L ^e   Morgan, K ^a   Baranes, T G ^a   Roca, J ^g   Rabinovich, R ^g   Millar, A ^b   Donnelly, S C ^d   Keatingse, V ^f   MacNee, W ^c   Stolk, J ^h   Hiemstra, P S ^h   Miniati, M ⁱ   Monti, S ⁱ   O'Connor, C M ^d   Kalsheker, N ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d School of Medicine and Medical Science

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

^f LETTERKENNY GENERAL HOSPITAL   (Ireland)

^g HOSPITAL CLÍNIC   (Spain)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROL GROUP; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LETTER; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; LUNG VENTILATION; MALE; MIDDLE AGED; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOKING;

AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VENTILATION; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38849094604     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00057107     Document Type: Letter

References (9)

1. Tanaka G, Sandford AJ, Burkett K, et al. Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers Eur Respir J 2007; 29: 34-41.
2. Chappell S, Daly L, Morgan K, et al. Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease Hum Mutat 2006; 27: 103-109.
3. Sinnwell JP, Schaid DJ, Yu Z. Statistical analysis of haplotypes. Version 1.2.2., http://cran.r-project.org/src/contrib/Descriptions/haplo.stats.html Date last update: June 2007.
4. SAS/Genetics User's Guide. Release 8.2. Cary, SAS Institute Inc., 2002.
5. Hersh CP, DeMeo DL, Lange C, et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations Am J Respir Cell Mol Biol 2005; 33: 71-78.
6. Higham MA, Pride NB, Alikhan A, Morrell NW. Tumour necrosis factor-a gene promoter polymorphism in chronic obstructive pulmonary disease Eur Respir J 2000; 15: 281-284.
7. Patuzzo C, Gilè LS, Zorzetto M, et al. Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis Chest 2000; 117: 1353-1358.
8. Ruse CE, Hill MC, Tobin M, et al. Tumour necrosis factor gene complex polymorphisms in chronic obstructive pulmonary disease Respir Med 2007; 101: 340-344.
9. Küçükaycan M, Van Krugten M, Pennings HJ, et al. Tumor necrosis factor-α +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease Respir Res 2002; 3: 29.